San Diego-based Adamis Pharmaceuticals Corporation, a biopharmaceutical company that specializes in the development and commercialization of products for various therapeutic areas, has added new items to its portfolio. The company's products are aimed at treating allergy, opioid overdose, respiratory, and inflammatory diseases. Among them are SYMJEPI epinephrine injectable pre-filled single-dose syringe products that can be used in emergency situations to treat acute allergic reactions, including anaphylaxis. Adamis also offers the ZIMHI naloxone injection to battle opioid overdose. The company was established in 2006 with its headquarters in San Diego, California.
Adamis Pharmaceuticals's ticker is ADMP
The company's shares trade on the NASDAQ stock exchange
They are based in San Diego, California
There are 51-200 employees working at Adamis Pharmaceuticals
It is adamispharmaceuticals.com
Adamis Pharmaceuticals is in the Healthcare sector
Adamis Pharmaceuticals is in the Drug Delivery industry
The following five companies are Adamis Pharmaceuticals's industry peers: